PDE4A and Alzheimer disease: The prominence of anti-inflammatory agents like quiflapon (leukotriene inhibitor) and zardaverine (PDE3/PDE4 inhibitor) in our analysis emphasizes the unique inflammatory signature of astrocytes compared to other cell types in AD pathogenesis.